Health Plan Barriers Threaten Migraine Treatment
Mounting access barriers to headache and migraine treatments have sparked concerns among patients and providers.
Medicare Rule Could Delay Migraine, Movement Disorder Treatment
New efforts to rein in Medicare costs could delay treatment for people who need botulinum toxins for migraine or movement disorders.
Veterans Issues Dominate Headache Policy Event
In a Tuesday policy panel sponsored by The Headache and Migraine Policy Forum, experts from across the health care and veterans support spectrum weighed in on how migraine and headache disorders impact veterans – and whether these women and men can access the treatment they need.
Who Are Headache Disorders & Migraine Hurting?
Who feels the impact of headache disorders and migraine? More people than you may think, according to a new video from The Headache & Migraine Policy Forum.
Headache: Veterans’ Battle after Service
Over the last few decades, improved body armor has helped protect America’s men and women in uniform from fatal complications such as those from close-proximity blasts. They’re surviving. They’re returning home to their spouses, partners, parents and children.
But many still have wounds – some visible, some invisible.
Awareness Month Highlights Migraine’s Impact, Lack of Treatments
Some wore shades, others “showed purple.” But advocates across the board used June’s Migraine & Headache Awareness Month to draw attention to a condition whose patients face debilitating symptoms and far too few treatment options.
Why Impact & Cost of Chronic Migraine Comorbidities Justify “Whole-Person” Care
Chronic migraine is seldom a lone condition, explains a new white paper from the Headache & Migraine Policy Forum.
Congress Urged to Prioritize Headache Research, Treatments
During today’s annual Headache on the Hill event, patients, physicians and advocates from the Alliance for Headache Disorders Advocacy will once again brief members of Congress on the impact of headache – and how better funding, more research and improved access to treatments could mitigate the conditions’ impact on patients.
